Skip to main content
Rural Health Information Hub
Rural Health Information Hub

FDA: Revocation of Two Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability

Source
Federal Register
Link
View Full Story
Date
Nov 20, 2024
Summary
The Food and Drug Administration has revoked Emergency Use Authorizations issued to Cue Health, Inc., related to COVID-19 detection and diagnosis tests. The revocations are effective October 9, 2024.
Tagged as
COVID-19 · Legislation and regulations · Pharmacy and prescription drugs